Synthesis and biological evaluation of amide derivatives of the quinazoline tethered (pyridyl)-1,2,4-thiadiazoles as anticancer agents

References

• Sultana, N.; Sarfraz, M.; Tanoli, S. T.; Akram, M. S.; Sadiq, A.; Rashid, U.; Tariq, M. I. Synthesis, Crystal Structure Determination, Biological Screening and Docking Studies of N1-Substituted Derivatives of 2,3-Dihydroquinazolin-4(1H)-One as Inhibitors of Cholinesterases. Bioorg. Chem. 2017, 72, 256–267. DOI: 10.1016/j.bioorg.2017.04.009.
   PubMed Web of Science ®Google Scholar
• Al-Salahi, R.; Abuelizz, H. A.; Ghabbour, H. A.; El-Dib, R.; Marzouk, M. Chem. Cent. J. 2016, 19, 10–21.
   Google Scholar
• Rakesh, K. P.; Manukumar, H. M.; Gowda, D. C. Schiff’s Bases of Quinazolinone Derivatives: Synthesis and SAR Studies of a Novel Series of Potential anti-Inflammatory and Antioxidants. Bioorg. Med. Chem. Lett. 2015, 25, 1072–1077. DOI: 10.1016/j.bmcl.2015.01.010.
   PubMed Web of Science ®Google Scholar
• Laddha, S. S.; Bhatnagar, S. P. A New Therapeutic Approach in Parkinson’s Disease: some Novel Quinazoline Derivatives as Dual Selective Phosphodiesterase 1 Inhibitors and anti-Inflammatory Agents. Bioorg. Med. Chem. 2009, 17, 6796–6802. DOI: 10.1016/j.bmc.2009.08.041.
   PubMed Web of Science ®Google Scholar
• McLaughlin, N. P.; Evans, P. Dihydroxylation of Vinyl Sulfones: Stereoselective Synthesis of (+)- and (-)-Febrifugine and Halofuginone. J. Org. Chem. 2010, 75, 518–521. DOI: 10.1021/jo902396m.
   PubMed Web of Science ®Google Scholar
• Jampilek, J.; Musiol, R.; Finster, J.; Pesko, M.; Carroll, J.; Kralova, K.; Vejsova, M.; O’Mahony, J.; Coffey, A.; Dohnal, J.; Polanski, J. Investigating Biological Activity Spectrum for Novel Styrylquinazoline Analogues. Molecules 2009, 14, 4246–4265. DOI: 10.3390/molecules14104246.
   PubMed Web of Science ®Google Scholar
• Asif, M. M. Int. J. Med. Chem. 2014, 18, 395–397.
   Google Scholar
• Selvam, T. P.; Kumar, P. V.; Kumar, A. S.; Emerson, I. A. J. Pharm. Res. 2010, 3, 1637–1647.
   Google Scholar
• Ugale, V. G.; Bari, S. B. Quinazolines: New Horizons in Anticonvulsant Therapy. Eur. J. Med. Chem. 2014, 80, 447–501. DOI: 10.1016/j.ejmech.2014.04.072.
   PubMed Web of Science ®Google Scholar
• Marvania, B.; Lee, P. C.; Chaniyara, R.; Dong, H.; Suman, S.; Kakadiya, R.; Chou, T.-C.; Lee, T.-C.; Shah, A.; Su, T.-L. Design, Synthesis and Antitumor Evaluation of Phenyl N-Mustard-Quinazoline Conjugates. Bioorg. Med. Chem. 2011, 19, 1987–1998. DOI: 10.1016/j.bmc.2011.01.055.
   PubMed Web of Science ®Google Scholar
• Ji, Q.; Yang, D.; Wang, X.; Chen, C.; Deng, Q.; Ge, Z.; Yuan, L.; Yang, X.; Liao, F. Design, Synthesis and Evaluation of Novel Quinazoline-2,4-Dione Derivatives as Chitin Synthase Inhibitors and Antifungal Agents. Bioorg. Med. Chem. 2014, 22, 3405–3413., DOI: 10.1016/j.bmc.2014.04.042.
   PubMed Web of Science ®Google Scholar
• Ryan, Q.; Ibrahim, A.; Cohen, M. H.; Johnson, J.; Ko, C.; Sridhara, R.; Justice, R.; Pazdur, R. FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That Overexpresses HER-2. Oncologist. 2008, 13, 1114–1119. DOI: 10.1634/theoncologist.2008-0816.
   PubMed Web of Science ®Google Scholar
• Tevaarwerk, A. J.; Kolesar, J. M. Lapatinib: A Small-Molecule Inhibitor of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor-2 Tyrosine Kinases Used in the Treatment of Breast Cancer. Clin. Ther. 2009, 31, 2332–2348. DOI: 10.1016/j.clinthera.2009.11.029.
   PubMed Web of Science ®Google Scholar
• Humphrey, J. M.; Ch Amberlin, A. R. Chemical Synthesis of Natural Product Peptides: Coupling Methods for the Incorporation of Noncoded Amino Acids into Peptides. Chem. Rev. 1997, 97, 2243–2266. DOI: 10.1021/cr950005s.
   PubMed Web of Science ®Google Scholar
• Fattori, D.; Porcelloni, M.; D’Andrea, P.; Catalioto, R.-M.; Ettorre, A.; Giuliani, S.; Marastoni, E.; Mauro, S.; Meini, S.; Rossi, C.; et al. Structure-Activity Relationships of 6-Methyl-Benzo[b]Thiophene-2-Carboxylic Acid (1-[(S)-1-Benzyl-4-[4-(Tetrahydropyran-4-Ylmethyl)Piperazin-1-yl]Butylcarbamoyl]Cyclopentyl)Amide, Potent Antagonist of the Neurokinin-2 Receptor. J. Med. Chem. 2010, 53, 4148–4165. DOI: 10.1021/jm100176s.
   PubMed Web of Science ®Google Scholar
• Pick, A.; Klinkhammer, W.; Wiese, M. Specific Inhibitors of the Breast Cancer Resistance Protein (BCRP). Chem. Med. Chem. 2010, 5, 1498–1505. DOI: 10.1002/cmdc.201000216.
   Google Scholar
• Galewicz-Walesa, K.; Pachuta-Stec, A. Med. Acad. Lublin 2003, 9, 118–125.
   Google Scholar
• Hegab, M. I.; Abdel-Fattah, A.-S. M.; Yousef, N. M.; Nour, H. F.; Mostafa, A. M.; Ellithey, M. Synthesis, X-Ray Structure, and Pharmacological Activity of Some 6,6-Disubstituted Chromeno[4,3-b]- and Chromeno- [3,4-c]-Quinolines. Arch. Pharm. 2007, 340, 396–403., DOI: 10.1002/ardp.200700089.
   PubMed Web of Science ®Google Scholar
• Xu, H.; Hu, X. H.; Zou, X. M.; Liu, B.; Zhu, Y. Q.; Wang, Y.; Hu, F. Z.; Yang, H. Z. Synthesis and Herbicidal Activities of Novel 3-N-Substituted Amino-6-Methyl-4-(3-Trifluoromethylphenyl)Pyridazine Derivatives. J. Agric. Food Chem. 2008, 56, 6567–6572. DOI: 10.1021/jf800900h.
   PubMed Web of Science ®Google Scholar
• Wu, R.; Cong, Z.; Du, X.-J.; Xiong, L.-X.; Yu, S.-J.; Liu, X. H.; Li, Z. M.; Zhao, W. G. Chem. Cent. J. 2012, 6, 99–103. DOI: 10.1186/1752-153X-6-99.
   PubMed Web of Science ®Google Scholar
• Huang, W. S.; Metcalf, C. A.; Sundaramoorthi, R.; Wang, Y.; Zou, D.; Thomas, R. M.; Zhu, X.; Cai, L.; Wen, D.; Liu, S.; et al. Discovery of 3-[2-(Imidazo[1,2-b]Pyridazin-3-yl)Ethynyl]-4-methyl-N-{4-[(4-Methylpiperazin-1-yl)Methyl]-3-(Trifluoromethyl)Phenyl}Benzamide (AP24534), a Potent, Orally Active Pan-Inhibitor of Breakpoint Cluster Region-Abelson (BCR-ABL) Kinase Including the T315I Gatekeeper Mutant. J. Med. Chem. 2010, 53, 4701–4719. DOI: 10.1021/jm100395q.
   PubMed Web of Science ®Google Scholar